FY2019 EPS Estimates for CRH Medical Corp (CRH) Cut by Analyst

CRH Medical Corp (TSE:CRH) – Investment analysts at Clarus Securities lowered their FY2019 earnings estimates for shares of CRH Medical in a research note issued on Wednesday, March 20th, Zacks Investment Research reports. Clarus Securities analyst N. Atkinson now anticipates that the company will post earnings of $0.01 per share for the year, down from their prior estimate of $0.09. Clarus Securities currently has a “Buy” rating on the stock. Clarus Securities also issued estimates for CRH Medical’s FY2020 earnings at $0.09 EPS.

Other equities research analysts have also issued research reports about the stock. TD Securities dropped their price objective on shares of CRH Medical from C$6.50 to C$5.50 and set a “buy” rating on the stock in a research note on Wednesday, January 9th. Acumen Capital dropped their price objective on shares of CRH Medical from C$6.25 to C$6.00 in a research note on Friday, March 15th.

Shares of TSE CRH traded up C$0.02 during midday trading on Friday, hitting C$3.77. 50,149 shares of the company traded hands, compared to its average volume of 131,030. CRH Medical has a 12-month low of C$3.37 and a 12-month high of C$5.91. The company has a debt-to-equity ratio of 50.94, a current ratio of 2.56 and a quick ratio of 2.46. The stock has a market capitalization of $268.92 million and a P/E ratio of 59.84.

CRH Medical (TSE:CRH) last announced its quarterly earnings results on Wednesday, March 13th. The company reported C$0.03 earnings per share (EPS) for the quarter, meeting the consensus estimate of C$0.03. The company had revenue of C$42.33 million for the quarter, compared to analysts’ expectations of C$41.45 million.

CRH Medical Company Profile

CRH Medical Corporation provides various products and services to gastroenterologists in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures.

Recommended Story: Why does a company issue an IPO?

Get a free copy of the Zacks research report on CRH Medical (CRH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CRH Medical (TSE:CRH)

Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.